ApicHope Pharmaceutical Co., Ltd
SHZ: 300723.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hanxiong Li
- Employees
- 1,484
- Headquarters
- Guangzhou, China
- IPO year
- 2017
- Market cap
- CN¥18.5B
- Website
- https://www.gdyph.com
Loading 300723…
Loading profile data…Frequently asked questions about 300723
What does ApicHope Pharmaceutical Co., Ltd (300723.SZ) do?
ApicHope Pharmaceutical Co., Ltd, together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. It offers anti-infection, pediatric, cardiovascular, genitourinary, respiratory, liver and digestion, and dermatological products, as well as anti-inflammatory and analgesic products. The com...
Where does 300723.SZ trade?
ApicHope Pharmaceutical Co., Ltd (300723.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300723.SZ in?
ApicHope Pharmaceutical Co., Ltd (300723.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of ApicHope Pharmaceutical Co., Ltd?
Hanxiong Li is the chief executive officer of ApicHope Pharmaceutical Co., Ltd (300723.SZ).
Where is ApicHope Pharmaceutical Co., Ltd headquartered?
ApicHope Pharmaceutical Co., Ltd is headquartered in China.
Does 300723.SZ pay a dividend?
Yes — ApicHope Pharmaceutical Co., Ltd (300723.SZ) paid a trailing twelve-month dividend of CNY 0.21 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300723.SZ go public?
ApicHope Pharmaceutical Co., Ltd (300723.SZ) completed its initial public offering in 2017.